POSTnote by Peter Border and Joanna Scales. It was first published on Wednesday, 14 January 2015. It was last updated on Wednesday, 14 January 2015.
Value Based Assessment of Drugs
In 2010, the Government proposed moving towards a broader value-based system for assessing and pricing branded drugs. Such an approach aims to ensure that the price the NHS pays for a medicine better reflects its benefits. This briefing outlines recent proposals to change the current assessment methods.
Secondary information
- Type
- Research briefing
- Reference
- POST-PN-487
- Subjects
- Cost effectiveness Cancer Finance Drugs NHS National Institute for Health and Care Excellence Cancer Drugs Fund
- Published by
- POST
- Link
- View this Research briefing on researchbriefings.parliament.uk
Librarians' tools
- Timestamp
- 2023-03-04 08:50:54 +0000
- URI
- http://data.parliament.uk/resources/346302
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/resources/346302
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/resources/346302
- Internal location
- http://researchbriefings.intranet.parliament.uk/ResearchBriefing/Summary/POST-PN-487